Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Perella Weinberg Partners
PWP
$1.29B
| $309K | ﹤0.01% |
31,555
-13,786
| -30% | -$118K |
|
3502
Spok Holdings
SPOK
$228M
| $309K | ﹤0.01% |
37,753
-697
| -2% | -$5.66K |
|
3503
PUT
Duke Energy
DUK
$97.8B
| $309K | ﹤0.01% |
+3,000
| New | +$288K |
|
3504
Vanguard Russell 1000 Growth ETF
VONG
$43.7B
| $309K | ﹤0.01% |
+5,600
| New | +$317K |
|
3505
BioAtla
BCAB
$5.46M
| $308K | ﹤0.01% |
747
+709
| +1,866% | +$294K |
|
|
PSTX
3506
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $308K | ﹤0.01% |
58,109
+26,650
| +85% | +$122K |
|
3507
KVH Industries
KVHI
$181M
| $308K | ﹤0.01% |
30,118
| – | – |
|
3508
Scholar Rock
SRRK
$5.67B
| $306K | ﹤0.01% |
33,826
+21,302
| +170% | +$171K |
|
3509
Clearwater Paper
CLW
$339M
| $306K | ﹤0.01% |
8,092
+3,583
| +79% | +$140K |
|
|
PRO
3510
DELISTED
PROS Holdings
PRO
| $305K | ﹤0.01% |
12,587
+9,900
| +368% | +$243K |
|
3511
MediciNova
MNOV
$65.5M
| $304K | ﹤0.01% |
148,400
-9,900
| -6% | -$21.9K |
|
3512
PUT
Caesars Entertainment
CZR
$6.06B
| $304K | ﹤0.01% |
+7,300
| New | +$325K |
|
3513
PUT
HP
HPQ
$24.9B
| $304K | ﹤0.01% |
+11,300
| New | +$313K |
|
3514
Energy Recovery
ERII
$446M
| $303K | ﹤0.01% |
14,778
+12,444
| +533% | +$272K |
|
|
LGO
3515
Largo
LGO
$59.8M
| $302K | ﹤0.01% |
56,080
| – | – |
|
3516
Merchants Bancorp
MBIN
$2.53B
| $302K | ﹤0.01% |
12,402
+10,616
| +594% | +$258K |
|
|
GGAA
3517
DELISTED
Genesis Growth Tech Acquisition Corp. Class A Ordinary Shares
GGAA
| $300K | ﹤0.01% |
28,984
| – | – |
|
3518
Blue Owl Capital
OWL
$6.96B
| $300K | ﹤0.01% |
28,322
-10,179
| -26% | -$107K |
|
|
TPIC
3519
DELISTED
TPI Composites
TPIC
| $300K | ﹤0.01% |
29,600
+23,507
| +386% | +$245K |
|
|
CBAY
3520
DELISTED
Cymabay Therapeutics
CBAY
| $300K | ﹤0.01% |
47,775
+42,722
| +845% | +$162K |
|
3521
AngioDynamics
ANGO
$611M
| $299K | ﹤0.01% |
21,728
+10,997
| +102% | +$153K |
|
3522
BioLife Solutions
BLFS
$1.53B
| $299K | ﹤0.01% |
16,410
+7,593
| +86% | +$157K |
|
3523
Investar Holding Corp
ISTR
$415M
| $299K | ﹤0.01% |
13,870
+2,618
| +23% | +$56.2K |
|
3524
Wave Life Sciences
WVE
$1.09B
| $296K | ﹤0.01% |
42,294
+38,563
| +1,034% | +$178K |
|
3525
Xometry
XMTR
$4.74B
| $295K | ﹤0.01% |
9,166
+7,733
| +540% | +$361K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.